Clinical Trial Update: Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial of mocetinostat in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Lymphoma

Drugs mentioned

• Mocetinostat (mocetinostat)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphoma, Relapsed and Refractory | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-03-08